홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
RPRX
#573
Royalty Pharma plc Class A Ordinary Shares
48.820
0
USD
+0.81%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+0.81%
월간 변동
+6.52%
6달 변화
+31.03%
년간 변동율
+31.03%
이전 종가
48.430
0
Open
48.820
0
Bid
Ask
Low
48.820
0
High
48.820
0
양
203
마켓
주식
헬스케어
RPRX
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
388.13 M
432.96 M
443.17 M
446.69 M
433.32 M
428.42 M
—
Valuation ratios
Enterprise value
29.42 B
27.35 B
25.83 B
21.89 B
20.17 B
27.82 B
100.77 B
Price to earnings ratio
31.16
39.04
394
11.17
13.36
21.71
70.31
Price to sales ratio
8.85
7.22
7.71
7.24
6.7
9.17
34.98
Price to cash flow ratio
9.24
8.19
8.05
5.7
5.47
8.76
32.76
Price to book ratio
6.31
4.19
3.07
2.61
2.18
3.37
5.6
EBITDA 비율에 대한 기업 가치
168.52 K
113.31 K
577.4 K
109.36 K
120.6 K
150.62 K
509.31 K
Profitability ratios
Return on assets %
0.06
0.04
0
0.07
0.05
0.04
0.04
Return on equity %
0.1
0.06
0
0.11
0.08
0.08
0.08
Return on invested capital %
45.75
39.11
7.99
38.15
30.83
34.06
34.9
Gross margin %
92.64
100.56
68.24
75.24
63.21
111.34
447.42
Operating margin %
75.17
62.49
13.73
63.37
57.1
65.58
262.81
EBITDA margin %
84.97
93.29
18.52
65.6
53.88
62.24
248.14
Net margin %
45.94
27.07
1.91
48.2
37.95
32.42
128.9
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.76
16.81
2.19
7.9
1.44
2.4
8.7
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.13
0.14
0.13
0.14
0.13
0.13
0.13
Solvency ratios
Debt to assets ratio
0.36
0.41
0.36
0.37
0.36
0.44
1.64
Debt to equity ratio
1.21
1.23
1.09
0.94
0.95
1.33
4.76
Long term debt to total assets ratio
0.36
0.41
0.36
0.37
0.36
0.44
1.64
Long term debt to total equity ratio
1.21
1.23
1.09
0.94
0.95
1.32
4.75
Per share metrics
Operating cash flow per share
3.35
3.32
4.9
4.96
4.66
4.41
4.4
EBIT per share
2.63
2.36
0.7
2.47
2.18
2.76
2.75
EBITDA per share
2.97
3.52
0.95
2.56
2.05
2.62
2.63
Total debt per share
9.58
11.69
13.97
10.18
11.13
15.22
54.5
Cash per share
3.4
3.61
3.96
0.82
1.66
1.13
5.89
Net current asset value per share
4.44
4.74
5.83
2.11
3.03
2.71
11.9
Tangible book value per share
12.76
13.91
12.85
10.83
11.69
9.84
40.86
Working capital per share
3.94
4.46
3.17
1.85
0.92
1.58
5.64
Book value per share
7.94
9.51
12.85
10.83
11.69
11.47
45.8
뉴스
Can Royalty Pharma (RPRX) Keep the Earnings Surprise Streak Alive?
Revolution Medicines: PDAC Data Wows Wall Street - Jury's Out On Further Upside (RVMD)
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Why Is Mirum Pharmaceuticals (MIRM) Down 3.6% Since Last Earnings Report?
Why Is Apellis Pharmaceuticals (APLS) Down 17.3% Since Last Earnings Report?
Why Is ImmunityBio (IBRX) Down 35.8% Since Last Earnings Report?
Defense Lifts Moat Stocks As Tech Stumbles
로열티 파마, TD Cowen 컨퍼런스에서 전략적 성장 인사이트 발표
Royalty Pharma at TD Cowen Conference: Strategic Growth Insights
Citizens reiterates Zymeworks stock rating on strong cash position
자임워크스, 지헤라 모멘텀으로 2025년 매출 176% 급증
로열티 파마, 아시아 확장 이끌 책임자로 케네스 선 임명